Terminal
Stocks
Spotlight
News

Stocks
Healthcare
OTC
IPHYF

Market Cap: $154.94M

IS

Innate Pharma S.A.

IPHYF

OTC (Other OTC)USD

Overview News Analyst Reports Financials Politician Trades Insider Trades Executive Patents Earnings Surprise

Cashu

Markets

By Cashu Markets. Providing market news, analysis, and research for investors worldwide.

Company

Stocks About Cashu Markets Contact

Legal

Terms of Service Privacy Policy

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Markets is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Markets is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Markets and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Financials

Profitability

Gross Profit Margin100.00%

EBITDA Margin-20.08%

EBIT Margin-20.58%

Pre-tax Margin-19.87%

Net Profit Margin-17.65%

Earnings Yield-34.09%

Valuation Multiples

Price / Book-6.65

Price / Sales53.17

Price / Earnings-2.87

PEG-0.29

Forward PEG-0.12

EV / Sales51.19

EV / EBITDA-2.55

EV / Operating Cash Flow-2.70

EV / Free Cash Flow-2.70

Price / Free Cash Flow-2.80

Price / Operating Cash Flow-2.73

Cash Flow & Capital

Free Cash Flow / Share-$0.58

Operating Cash Flow / Share-$0.58

Free Cash Flow Yield-35.70%

Capex / Revenue5.02%

Capex / Operating Cash Flow-0.27%

Capex / Depreciation0.10

Stock Compensation / Revenue55.76%

Dividend Payout Ratio0.00%

Dividend Yield0.00%

Liquidity & Leverage

Current Ratio1.27

Quick Ratio1.27

Cash Ratio0.77

Debt / Assets0.36

Debt / Capital25.98

Debt / Equity-1.04

Long-Term Debt / Capital-1.70

Debt / Market Cap14.97%

Net Debt / EBITDA0.10

Solvency Ratio-0.57

Financial Leverage-2.89

Efficiency & Working Capital

Asset Turnover0.04

Fixed Asset Turnover0.64

Inventory Turnover0.00

Receivables Turnover0.37

Payables Turnover1.36

Days Sales Outstanding996.65

Days Inventory Outstanding0

Days Payables Outstanding267.56

Operating Cycle996.65

Cash Conversion Cycle729.09

Working Capital Turnover0.12

Returns & Quality

Return on Equity5.94%

Return on Assets-78.41%

Return on Invested Capital-1.56%

ROCE-2.20%

Return on Tangible Assets-78.41%

Operating Return on Assets-73.70%

Income Quality1.07

Tax Burden0.89

Interest Burden0.97

Balance Sheet & Intrinsic Metrics

Enterprise Value$142.66M

Invested Capital$14.42M

Working Capital$10.06M

Tangible Asset Value$-21.7M

Net Current Asset Value$-37.71M

Graham Net-Net-$0.49

Book Value / Share-$0.24

Tangible Book Value / Share-$0.24

Cash / Share$0.38

Financial Health Scores

Piotroski Score3

Altman Z-Score-13.40

Revenue$18.6M

EBIT$-97.64M

Market Cap$136.2M

Working Capital$10.06M

Retained Earnings$-435.38M

Total Assets$62.7M

Total Liabilities$84.39M